Veterinary Medicines

MYXOREN, liofilizatas ir skiediklis injekcinei suspensijai

Authorised
  • Myxoma virus, strain CAMP V-219, Live
Download as PDF

Product identification

Medicine name:
MYXOREN, liofilizatas ir skiediklis injekcinei suspensijai
Active substance:
  • Myxoma virus, strain CAMP V-219, Live
Target species:
  • Rabbit
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Myxoma virus, strain CAMP V-219, Live
    125893.00
    50% tissue culture infectious dose
    /
    1.00
    dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Rabbit
      • Not specified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI08AD02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta, a.s.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/02/1428/001-019
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 16/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."